Two studies of Remsima SC shows switching to subcutaneous therapy has no impact on treatment for inflammatory bowel disease – Celltrion Healthcare

Celltrion Healthcare announced two data sets relating to the use of the subcutaneous formulation of infliximab, Remsima SC (CT-P13 SC), in inflammatory bowel disease (IBD). The first study investigated clinical impact of switching from intravenous (IV) to subcutaneous (SC) treatment of infliximab in patients with Crohn’s disease (CD) or ulcerative colitis (UC) from the pivotal randomised controlled trial of CT-P13 […]

Ultra-processed food intake linked to inflammatory bowel disease

Consumption of ultra-processed foods appears to be linked to an increased risk of inflammatory bowel disease (IBD), researchers reported on July 15, 2021 in the BMJ/British Medical Journal. “Higher intake of ultra-processed food was positively associated with risk of IBD. Further studies are needed to identify the contributory factors within ultra-processed foods,” the authors said. Ultra-processed foods include packaged baked […]